Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1989 2
1990 1
1995 2
1996 1
1998 1
1999 2
2000 1
2001 2
2003 2
2005 4
2006 2
2007 2
2008 2
2009 4
2010 4
2011 5
2012 4
2013 9
2014 10
2015 6
2016 10
2017 12
2018 16
2019 27
2020 20
2021 31
2022 41
2023 50
2024 51

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitors: a promising anticancer therapy.
Singh S, Hassan D, Aldawsari HM, Molugulu N, Shukla R, Kesharwani P. Singh S, et al. Among authors: hassan d. Drug Discov Today. 2020 Jan;25(1):223-229. doi: 10.1016/j.drudis.2019.11.003. Epub 2019 Nov 15. Drug Discov Today. 2020. PMID: 31738877 Review.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4. N Engl J Med. 2021. PMID: 34347950 Free PMC article. Clinical Trial.
Pharmacological management of transthyretin amyloid cardiomyopathy: a scoping review.
Rehman S, Masthan SS, Ibrahim R, Pham HN, Hassan D, Ahmad F, Asif MS, Safdar A, Anwar Z, Raza S, William P. Rehman S, et al. Among authors: hassan d. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):547-556. doi: 10.1093/ehjcvp/pvae044. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38830793 Review.
AKT and the Hallmarks of Cancer.
Sementino E, Hassan D, Bellacosa A, Testa JR. Sementino E, et al. Among authors: hassan d. Cancer Res. 2024 Oct 22. doi: 10.1158/0008-5472.CAN-24-1846. Online ahead of print. Cancer Res. 2024. PMID: 39437156
5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy.
Valencia-Lazcano AA, Hassan D, Pourmadadi M, Shamsabadipour A, Behzadmehr R, Rahdar A, Medina DI, Díez-Pascual AM. Valencia-Lazcano AA, et al. Among authors: hassan d. Eur J Med Chem. 2023 Jan 15;246:114995. doi: 10.1016/j.ejmech.2022.114995. Epub 2022 Dec 1. Eur J Med Chem. 2023. PMID: 36493619 Review.
Implication of endoplasmic reticulum stress and mitochondrial perturbations in remote liver injury after renal ischemia/reperfusion in rats: potential protective role of azilsartan.
Elrashidy RA, Zakaria EM, Hasan RA, Elmaghraby AM, Hassan DA, Abdelgalil RM, Abdelmohsen SR, Negm AM, Khalil AS, Eraque AMS, Ahmed RM, Sabbah WS, Ahmed AA, Ibrahim SE. Elrashidy RA, et al. Among authors: hassan da. Redox Rep. 2024 Dec;29(1):2319963. doi: 10.1080/13510002.2024.2319963. Epub 2024 Feb 27. Redox Rep. 2024. PMID: 38411133 Free PMC article.
286 results